The spiraling cost of developing a new drug, which organisations
such as the USA-based Tufts Centre for the Study of Drug
Development estimate to be between $800m and $1.2bn, means that
companies wishing to create innovative medications...
UK specialty pharmaceutical company Glide Pharma has signed a deal
with a "leading" pharmaceutical company, under which the as yet
unidentified firm will evaluate Glide's Solid Dose Injection system
for the administration...
A multinational, multidisciplinary initiative involving scientists,
public health workers, police and government officials could
provide a cogent model for rooting out and stamping out
counterfeiting of essential and lifesaving drugs.
Bayer Healthcare is to deploy a new technique, developed by
Millipore, for genetically engineering cells to produce
pharmaceutically useful proteins that could both increase the yield
and accelerate drug production.
Bosch Packaging Technology will be rolling out a range of new and
recently launched processing and packaging solutions at the
Interpack 2008 exhibition in Düsseldorf, Germany this April,
including a new line for high-potency compounds.
Novartis has lent impetus to the growing trend towards
philanthropic R&D in the pharmaceutical industry by opening a
new research institute in Siena, Italy "with a non-profit
mission to exclusively focus on the development...
A new consortium in Scotland is to develop a new 3D cell assay for
use in drug discovery and for safety evaluation prior to clinical
trials, in the hope of cutting costs and reducing the use of
animals for testing.